top of page

Key Features

  • Rapid screening with interpretable reports

  • Annular sizing, device oversizing and more

  • Automated neo-LVOT with comparison across device sizes

  • IFU-based or customizable criteria

TMVR (REC)

  • Regulatory: Research Only

  • Clinical Applications: Mitral Regurgitation

  • Modality: CT

Latest News

REC Pre-Screening resulted in "reliable anatomical measurements" and "good accuracy compared to Abbott core lab decision making" for Tendyne, presented by Dr. Jonathan Curio (University Hospital Cologne).

4th June 2024, New York Valves

Press Release: LARALAB GmbH Launches Groundbreaking New Product 'REC - Rapid Eligibility Check'.

13th May, 2024

Peer-Reviewed Publications

bottom of page